Phanes Therapeutics reveals SPECpair™ technology platform that enhances manufacturability of bispecific antibodies
September 10th, 2021 | 🕒
https://www.ispeech.org SAN DIEGO, Sept. 10, 2021 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative drug discovery research
Gloss